Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,229 signal articles · 4 in last 24h · 160,153 total before filter · latest 22h ago
4last 24h
667last 7d
91● bullish (7d)
69● bearish (7d)
214publishers
AllMacro134Earnings174M&A71Regulatory13Product11Analyst18
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Google Faces 6 Years Of Oversight Globally
MediaPost15d agoneutral
Google Faces 6 Years Of Oversight Globally

Judge Brinkema filed a full remedies opinion in U.S. v. Google's ad-tech monopoly suit. The court publicly released the unredacted document. Both sides were given 14 days to propose redactions for confidential business information, but neither side did so.

Forkast News15d agoneutral
Visa ‘Hundreds’ vs ‘Millions’ Gap: Commercial Launch Data Shows the Agent Commerce Ceiling

In December 2025, Visa reported that it had completed “hundreds” of secure, agent-initiated transactions in a closed beta. By the 2026 holiday season, the company projects that “millions” of consumers will use AI agents to complete purchases. This numerical gap — the distance between a few hundred test cases and a multi-million-transaction reality — is […]

Meta (META) Overhauls Instagram and Facebook for Teens after its $17 Billion Settlement
Insider Monkey15d agoneutral
Meta (META) Overhauls Instagram and Facebook for Teens after its $17 Billion Settlement

On August 26, 2026, Meta Platforms, Inc. (NASDAQ:META) agreed to pay up to $17 billion over 10 years and to overhaul how teenagers use Instagram and Facebook, settling a lawsuit brought by more than 40 states, the District of Columbia, and several territories over claims that its platforms fueled social media addiction among young people. […]

Forget the AI Doom Headlines. Watch This AMD Number Instead.
TIKR15d agoneutral
Forget the AI Doom Headlines. Watch This AMD Number Instead.

Key TakeawaysAMD fell more than 4% on September 14 after Anthropic, OpenAI and xAI executives publicly warned about the pace of AI development, then rebounded to roughly $549 by September 17, up more than 7% on the day. Wall Street’s price targets never wavered during the panic.

Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising
Trefis15d agoneutral
Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising

Boston Scientific (BSX) has fallen about 54% since late December 2025, and it now sits at $43.91, just above a 52-week low of $42.63. Device peers were mixed over the same nine months: Abbott lost about 17%, Medtronic barely moved, and Johnson & Johnson rose about 32%. The market repriced Boston Scientific's growth rate after management concentrated its guidance cut in two core product lines.